Literature DB >> 8858602

Species variation in the testicular angiotensin converting enzyme promoter studied in transgenic mice.

R P Erickson1, S Kessler, H Kremling, G C Sen.   

Abstract

We have studied the control of transcription of the testicular angiotensin converting enzyme (ACEt) in normal and transgenic mice. Northern analyses, including a developmental curve and separated germ cells, for ACEt mRNA suggest predominantly post-meiotic expression. Mice transgenic for a construct containing the proximal 298 bp of the rabbit ACEt promoter, with chloramphenicol acetyl transferase (CAT) as a recorder, showed correct tissue regulation while a 86 bp fragment of the promoter led to no expression. Many candidate transacting factor binding elements, previously identified as candidate regulators of transcription driving spermatogenesis, are scattered across this 298 bp in the rabbit (but not the mouse) promoter and may lead to tissue specificity. The recent finding that the proximal 91 bp of the mouse ACEt promoter leads to tissue specific expression of a recorder gene (Howard et al., 1993) emphasizes the difference between the two species and the importance of a cAMP response element (CRE) within this fragment for tissue specific expression. This CRE is conserved in the rabbit promoters we used.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858602     DOI: 10.1002/(SICI)1098-2795(199607)44:3<324::AID-MRD6>3.0.CO;2-O

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  2 in total

Review 1.  Lessons from knockout and transgenic mice for infertility in men.

Authors:  J P Venables; H J Cooke
Journal:  J Endocrinol Invest       Date:  2000-10       Impact factor: 4.256

2.  Selective restoration of male fertility in mice lacking angiotensin-converting enzymes by sperm-specific expression of the testicular isozyme.

Authors:  P Ramaraj; S P Kessler; C Colmenares; G C Sen
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.